Johnson & Johnson sued for $70M by oral cancer test maker
Johnson & Johnson, the world’s second-largest maker of health care products, was sued for at least $70 million by a company that claims it interfered in a contract over distribution of an oral cancer test. Oral Cancer Prevention International Inc., a private company based in Suffern, N.Y., sued over a contract it signed in February 2010 with OraPharma Inc., then a J&J unit. OraPharma agreed to distribute OCPI’s Oral CDx Brush Test, which identifies precancerous cells in the mouth, according to the complaint filed in federal court in Trenton, N.J.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063